Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus: a post hoc analysis of the 4D study
Background Apolipoprotein A-IV (apoA-IV) is an anti-atherogenic and anti-oxidative plasma glycoprotein involved in reverse cholesterol transport. The aim of this study was to examine the association between apoA-IV and all-cause mortality, cardiovascular endpoints and parameters of protein-energy wa...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
December 2012
|
| In: |
Journal of internal medicine
Year: 2012, Jahrgang: 272, Heft: 6, Pages: 592-600 |
| ISSN: | 1365-2796 |
| DOI: | 10.1111/j.1365-2796.2012.02585.x |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1111/j.1365-2796.2012.02585.x Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2796.2012.02585.x 
|
| Verfasserangaben: | B. Kollerits, V. Krane, C. Drechsler, C. Lamina, W. März, E. Ritz, C. Wanner, F. Kronenberg |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 158221901X | ||
| 003 | DE-627 | ||
| 005 | 20230427193153.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181023s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/j.1365-2796.2012.02585.x |2 doi | |
| 035 | |a (DE-627)158221901X | ||
| 035 | |a (DE-576)51221901X | ||
| 035 | |a (DE-599)BSZ51221901X | ||
| 035 | |a (OCoLC)1341021321 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kollerits, Barbara |d 1979- |e VerfasserIn |0 (DE-588)1169707386 |0 (DE-627)1035312042 |0 (DE-576)512218412 |4 aut | |
| 245 | 1 | 0 | |a Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus |b a post hoc analysis of the 4D study |c B. Kollerits, V. Krane, C. Drechsler, C. Lamina, W. März, E. Ritz, C. Wanner, F. Kronenberg |
| 264 | 1 | |c December 2012 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published: 14 August 2012 | ||
| 500 | |a Gesehen am 23.10.2018 | ||
| 520 | |a Background Apolipoprotein A-IV (apoA-IV) is an anti-atherogenic and anti-oxidative plasma glycoprotein involved in reverse cholesterol transport. The aim of this study was to examine the association between apoA-IV and all-cause mortality, cardiovascular endpoints and parameters of protein-energy wasting and nutrition in haemodialysis patients. Methods This post hoc analysis was performed in the German Diabetes Dialysis Study (4D Study) evaluating atorvastatin in 1255 haemodialysis patients with type 2 diabetes mellitus, followed for a median of 4 years. The association between apoA-IV and relevant outcomes was analysed using Cox proportional hazards regression analyses. Body mass index (BMI) was used as a marker of protein-energy wasting. In addition, a definition of extended wasting was applied, combining median values of BMI, serum albumin, creatinine and sensitive C-reactive protein, to classify patients. Results Mean (±SD) apoA-IV concentration was 49.8 ± 14.2 mg dL−1. Age- and gender-adjusted apoA-IV concentrations were strongly associated with the presence of congestive heart failure at baseline [odds ratio = 0.81, 95% confidence interval (CI) 0.74-0.88 per 10 mg dL−1 increase; P < 0.001). During the prospective follow-up, the strongest association was found for all-cause mortality [hazard ratio (HR) = 0.89, 95% CI 0.85-0.95, P = 0.001), which was mainly because of patients with BMI > 23 kg m−2 (HR = 0.87, 95% CI 0.82-0.94, P < 0.001) and those in the nonwasting group according to the extended definition (HR = 0.89, 95% CI 0.84-0.96, P = 0.001). This association remained significant after additionally adjusting for parameters associated with apoA-IV at baseline. Further associations were observed for sudden cardiac death. ApoA-IV was less strongly associated with atherogenic events such as myocardial infarction. Conclusions Low apoA-IV levels seem to be a risk predictor of all-cause mortality and sudden cardiac death. This association might be modified by nutritional status. | ||
| 650 | 4 | |a all-cause mortality | |
| 650 | 4 | |a apolipoprotein A-IV | |
| 650 | 4 | |a haemodialysis | |
| 650 | 4 | |a nutrition | |
| 650 | 4 | |a protein-energy wasting | |
| 700 | 1 | |a März, Winfried |d 1958- |e VerfasserIn |0 (DE-588)1027603599 |0 (DE-627)729463605 |0 (DE-576)373454635 |4 aut | |
| 700 | 1 | |a Ritz, Eberhard |d 1938-2023 |e VerfasserIn |0 (DE-588)106673386 |0 (DE-627)610528866 |0 (DE-576)311552501 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of internal medicine |d Oxford [u.a.] : Wiley-Blackwell, 1863 |g 272(2012), 6, Seite 592-600 |h Online-Ressource |w (DE-627)320457826 |w (DE-600)2006883-9 |w (DE-576)091142881 |x 1365-2796 |7 nnas |a Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus a post hoc analysis of the 4D study |
| 773 | 1 | 8 | |g volume:272 |g year:2012 |g number:6 |g pages:592-600 |g extent:9 |a Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus a post hoc analysis of the 4D study |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |t Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus |d 2012 |w (DE-627)1447887646 |w (DE-576)377887641 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/j.1365-2796.2012.02585.x |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2796.2012.02585.x |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181023 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 106673386 |a Ritz, Eberhard |m 106673386:Ritz, Eberhard |d 910000 |d 910100 |e 910000PR106673386 |e 910100PR106673386 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 1027603599 |a März, Winfried |m 1027603599:März, Winfried |d 60000 |d 65300 |e 60000PM1027603599 |e 65300PM1027603599 |k 0/60000/ |k 1/60000/65300/ |p 5 | ||
| 999 | |a KXP-PPN158221901X |e 3029527360 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["First published: 14 August 2012","Gesehen am 23.10.2018"],"recId":"158221901X","name":{"displayForm":["B. Kollerits, V. Krane, C. Drechsler, C. Lamina, W. März, E. Ritz, C. Wanner, F. Kronenberg"]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"December 2012"}],"language":["eng"],"person":[{"role":"aut","display":"Kollerits, Barbara","given":"Barbara","family":"Kollerits"},{"family":"März","given":"Winfried","display":"März, Winfried","role":"aut"},{"display":"Ritz, Eberhard","role":"aut","family":"Ritz","given":"Eberhard"}],"title":[{"title":"Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus","subtitle":"a post hoc analysis of the 4D study","title_sort":"Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus"}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"eki":["320457826"],"doi":["10.1111/(ISSN)1365-2796"],"issn":["1365-2796"],"zdb":["2006883-9"]},"pubHistory":["1.1863 - 4.1868; [N.F.] 1.1869 -"],"part":{"year":"2012","extent":"9","volume":"272","text":"272(2012), 6, Seite 592-600","issue":"6","pages":"592-600"},"origin":[{"publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","dateIssuedDisp":"1863-","dateIssuedKey":"1863","publisherPlace":"Oxford [u.a.] ; Oxford [u.a.] ; Oxford [u.a.]"}],"titleAlt":[{"title":"Medicinskt archiv"},{"title":"Nordiskt medicinskt arkiv"},{"title":"Acta medica Scandinavica"}],"recId":"320457826","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Journal of internal medicine","title":"Journal of internal medicine"}],"language":["eng"],"note":["Gesehen am 08.04.22"],"disp":"Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus a post hoc analysis of the 4D studyJournal of internal medicine"}],"physDesc":[{"extent":"9 S."}],"id":{"doi":["10.1111/j.1365-2796.2012.02585.x"],"eki":["158221901X"]},"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a KOLLERITSBAPOLIPOPRO2012 | ||